Eisai Inc. Opens New US Headquarters on ON3 Campus in Nutley

Eisai Inc., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., has relocated its US headquarters to the ON3 Campus at 200 Metro Blvd. in Nutley. The move supports Eisai’s new hybrid workstyle and human health care mission to deliver life-changing therapies and health-related solutions.